Found 5 matching trials
A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer
PHASE1The main objectives of this study are:
* To determine the recommended dose...
Location
St Marianna University Hospital
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer
PHASE1The primary objective of the phase 1 portion of this study is to determine ...
Location
The University of Arizona Cancer Center
An Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder Cancer
N/AThis is an open-label, expanded access protocol to continue administration ...
Status
No Longer Available
Location
Multiple Locations
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
PHASE1This is a three-part, open-label, safety, tolerability, and PK study of FPA...
Location
City of Hope Comprehensive Cancer Center
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer
PHASE2The main objective of the Phase 2 part of the study is to evaluate the effi...
Location
University of Arizona Cancer Center